A New Blood Collection Device Minimizes Cellular <scp>DNA</scp> Release During Sample Storage and Shipping When Compared to a Standard Device

Abstract

BCTs prevent increases in gDNA levels that can occur during sample storage and shipping. This new device permits low abundance DNA target detection and allows accurate cfDNA concentrations.